NucleoSpin Blood, Mini kit for DNA from blood

Product configuration

Selling unit

Do you have any questions?
Please contact us.
Select variant first $0.00 * (0% Saved)

*taxes and shipping not included

740951.50 031040442001
Package unit 50 Preps
Quantity:
Mini spin kit for versatile purification of high quality DNA from blood more

Mini spin kit for versatile purification of high quality DNA from blood

Application Isolation of DNA
Selling unit 10 Prep(s), 50 Prep(s), 250 Prep(s)
Target DNA
CE certified No, research use only
Technology Silica membrane technology
Brand NucleoSpin
Format Mini prep
Handling Centrifugation
Automated use No
Sample material Blood, Body fluids, Buffy coat, Cells, Plasma, Platelets, Serum
Sample amount 5–200 µL whole blood (human or animal, fresh or frozen, treated with citrate, EDTA, heparin, or CPDA), buffy coat, platelets, body fluids, serum, plasma, < 5 x 10⁶ human/animal cells cultured cells
Fragment size 200 bp–approx. 50 kbp
Typical yield 4–6 µg
Typical concentration 40–100 ng/µL
Theoretical binding capacity 60 µg
Typical purity A260/A280 1.6–1.9
Elution volume 60–200 µL
Preparation time 30 min/prep
Typical downstream application enzymatic reactions, Next Generation Sequencing, PCR, Southern blotting
Storage temperature 15–25 °C / 59–77 °F
Shelf life (from production) 27 Month(s)
Hazardous material Yes
Learn more

NucleoSpin Blood

  • Ready-to-use DNA in less than 30 min
  • Complete removal of PCR inhibitors
  • Suitable for whole blood, treated with citrate, EDTA, heparin, CPDA
  • Consistently high DNA yields

NucleoSpin Blood - Procedure

NucleoSpin Blood kits are designed for rapid purification of genomic DNA from whole blood, serum, plasma, and body fluids (amniotic fluid, liquor etc.). Animal or human blood samples, fresh or frozen material, can be processed conveniently.
The NucleoSpin Blood method is based on a specially treated silica membrane with a high binding capacity for nucleic acids. The obtained DNA can be used directly for PCR (e.g., HLA typing), Southern blotting, or any kind of enzymatic reactions.

The kit allows the isolation of 4–6 μg of pure genomic DNA from 200 μL whole blood with an A260/A280 ratio between 1.60 and 1.90 and a typical concentration of 40–60 ng per μL. Due to the high binding capacity of the NucleoSpin Blood membrane, yields of up to 60 μg DNA are possible (from starting materials like buffy coat or lymphocyte-enriched samples).
With the NucleoSpin Blood method, genomic DNA is prepared from whole blood. Lysis is achieved by incubation of whole blood in a solution containing large amounts of chaotropic ions in the presence of proteinase K at 70 °C. Appropriate conditions for binding of DNA to the silica membrane of the NucleoSpin Blood columns are created by addition of ethanol to the lysate.

Superior purification with the NucleoSpin Blood kit

DNA was isolated from human blood samples (n = 3) using the NucleoSpin Blood kit and competitor kits from T, AJ and Q (light grey bars for A₂₆₀/A280 and dark grey bars for A260/A230 ratios). The purity was determined by UV-spectrometry resulting in an average A260/A280 value for the NucleoSpin Blood kit of 1.89 ± 0.03 (dark blue bar) and an average A260/A230 value (light blue bar) of 1.88 ± 0.03.

Competitive sensitivity measured by qPCR

DNA was extracted from human blood samples the with NucleoSpin Blood kit (dark blue bar) and the competitor kits from T, AJ and Q (grey bars). Samples were analyzed in triplicate by qPCR for β-globin (268 bp). With an average amplification cycle of 23.1 the results demonstrate the competitive performance and reliably high quality of DNA extraction with the NucleoSpin Blood kit.

Continue reading